FibroGen Stock News

SAN FRANCISCO, April 8, 2021 /PRNewswire/ -- Hagens Berman urges FibroGen, Inc. (NASDAQ: FGEN) investors with significant losses to submit your losses now. The firm is investigating possible securi

LOS ANGELES--(BUSINESS WIRE)---- $FGEN #FGEN--INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against FibroGen, Inc.

MILWAUKEE, April 8, 2021 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against FibroGen (NASDAQ: FGEN).  The investigation results from inaccurate statements Fibrogen ma

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In FibroGen To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile C

NEW YORK--(BUSINESS WIRE)---- $FGEN--The law firm of Kirby McInerney LLP is investigating potential claims against FibroGen Inc. (“FibroGen” or the “Company”) (NASDAQ: FGEN). The investigation

LOS ANGELES--(BUSINESS WIRE)---- $FGEN #investors--The Law Offices of Frank R. Cruz Continues Its Investigation of FibroGen Inc. (FGEN) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)---- $FGEN #FGEN--INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against FibroGen, Inc.

LOS ANGELES--(BUSINESS WIRE)---- $FGEN #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a national investor rights law firm, continues its investigation on behalf of FibroGen Inc. (“Fibrogen�

BENSALEM, Pa.--(BUSINESS WIRE)---- $FGEN #CLASSACTION--Law Offices of Howard G. Smith continues its investigation on behalf of FibroGen Inc. (“Fibrogen” or the “Company”) (NASDAQ: FGEN) invest

NEW YORK, April 7, 2021 /PRNewswire/ -- Wolf Popper LLP is investigating potential securities fraud claims on behalf of purchasers of FibroGen, Inc. (NASDAQ: FGEN) common stock. FibroGen is a biopharm

San Francisco, California--(Newsfile Corp. - April 7, 2021) - Berman Tabacco, a national law firm representing investors, is investigating potential securities law claims against FibroGen Inc. ("Fibro

Atlanta, Georgia--(Newsfile Corp. - April 7, 2021) - Holzer & Holzer, LLC is investigating whether FibroGen, Inc. ("FibroGen" or the "Company") (NASDAQ: FGEN) complied with federal securities laws. On

The company disclosed a bombshell related to its safety results for lead candidate roxadustat.

LOS ANGELES--(BUSINESS WIRE)---- $FGEN #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on

SAN DIEGO, April 7, 2021 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by FibroGen, Inc. ("FibroGen" or the "Com